CD14 is a decision-maker between Fas-mediated death and inflammation.

Area of Science:

• Immunology
• Cell Biology

Background:

• Fas receptor signaling was traditionally viewed as a pro-death pathway.
• Recent studies suggest Fas can also mediate pro-inflammatory responses in disease.
• The mechanisms governing this switch in Fas signaling remain unclear.

Purpose of the Study:

• To investigate the role of CD14 in modulating Fas-mediated signaling outcomes.
• To elucidate how Fas signaling switches between pro-death and pro-inflammatory pathways.

Main Methods:

• Utilized myeloid cells (macrophages and neutrophils) lacking CD14 (Cd14-/-).
• Analyzed Fas receptor internalization and downstream signaling pathways.
• Assessed NF-κB activation and cytokine release following FasL stimulation.

Main Results:

• CD14 deficiency protected myeloid cells from FasL-induced apoptosis.
• Cd14-/- myeloid cells exhibited increased NF-κB activation and cytokine production.
• CD14 was essential for Fas-mediated signaling through TRIF, including pro-death complex formation.

Conclusions:

• CD14 acts as a critical regulator of Fas receptor internalization.
• CD14 availability determines whether Fas signaling results in cell death or inflammation.
• Targeting CD14 could modulate Fas-mediated immune responses in pathological conditions.